Want to see FR:CLARI full AI Analyst Report?
CLARI Stock Chart & Stats
€3.94
€0.02(0.46%)
At close: 4:00 PM EDT
€3.94
€0.02(0.46%)
Day’s Range― - ―
52-Week Range€3.27 - €4.92
Previous CloseN/A
Volume125.55K
Average Volume (3M)711.69K
Market Cap
€1.43B
Enterprise Value€8.69K
Total Cash (Recent Filing)€1.42B
Total Debt (Recent Filing)€8.35B
Price to Earnings (P/E)99.8
Beta1.20
Next Earnings
Mar 04, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding357,540,860
10 Day Avg. Volume394,627
30 Day Avg. Volume711,689
Financial Highlights & Ratios
PEG Ratio-8.51
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio2.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.70Price Target Upside19.29% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.41
Revenue Forecast (FY)€5.39B
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue GrowthClariane's recurring, utilization-driven care model shows multi-year top-line momentum, with 2025 revenue up ~16.5% vs 2024. Sustained demand for elderly, rehab and home-care services and public funding links support durable revenue expansion and predictable utilization over months.
Stable Operating MarginsConsistent EBITDA margins near 19–20% indicate structural operational efficiency across care, clinic and home-service segments. Stable operating profitability supports reinvestment into facilities and staffing, insulating core cash generation from short-term volume swings over the medium term.
Consistent Cash GenerationPositive and improving operating cash flow and FCF (~€578M in 2025) provide sustained internal financing for capex, working capital and service delivery. Reliable cash conversion from operations is a durable strength supporting operations and moderate strategic actions over the next 2–6 months.
Bears Say
Elevated And Rising LeverageLeverage increasing to ~3.14x heightens sensitivity to interest costs and refinancing risk. High debt limits financial flexibility for M&A, capex or wage inflation responses, making the business more exposed to funding-market shifts and earnings shocks over the medium term.
Weak/Volatile Net ProfitabilityDespite steady operating margins, net profitability has been inconsistent with losses in 2023–24 and near-breakeven in 2025. Non-operating costs and financing pressures are eroding bottom-line resilience, limiting retained earnings build-up and increasing reliance on cash generation to cover obligations.
Limited Debt Paydown CapacityAlthough FCF is positive, it covers only a portion of the debt each year, implying moderate rather than strong deleveraging capacity. Large absolute debt plus only partial coverage of obligations raises refinancing and interest-coverage risk if cashflows or funding conditions weaken.
Clariane News
CLARI FAQ
What was Clariane’s price range in the past 12 months?
Clariane lowest stock price was €3.27 and its highest was €4.92 in the past 12 months.
What is Clariane’s market cap?
Clariane’s market cap is €1.43B.
When is Clariane’s upcoming earnings report date?
Clariane’s upcoming earnings report date is Mar 04, 2027 which is in 209 days.
How were Clariane’s earnings last quarter?
Clariane released its earnings results on Jul 29, 2026. The company reported -€0.133 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Clariane overvalued?
According to Wall Street analysts Clariane’s price is currently Undervalued.
Does Clariane pay dividends?
Clariane pays a Annually dividend of €0.25 which represents an annual dividend yield of N/A. See more information on Clariane dividends here
What is Clariane’s EPS estimate?
Clariane’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clariane have?
Clariane has 357,540,860 shares outstanding.
What happened to Clariane’s price movement after its last earnings report?
Clariane reported an EPS of -€0.133 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.118%.
Which hedge fund is a major shareholder of Clariane?
Currently, no hedge funds are holding shares in FR:CLARI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Clariane
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
CLARI Stock 12 Month Forecast
Average Price Target
€4.70
▲(19.29% Upside)